Motley Rice - Attorneys at Law
Navigation
Main navigation
Motley Rice represents clients across many areas.
Learn about the cases Motley Rice is actively representing clients in or cases that we've litigated previously.
Ozempic® users are filing lawsuits for vision loss, ileus, and other serious injuries.
Lawsuits allege talcum powder use is linked to reproductive organ cancer for women.
Lawsuits allege toxic heavy metals in baby food damage infants’ brain development.
Social media companies are being sued over alleged teenage mental health harms.
Meta is being sued for teenage mental health harms allegedly caused by Facebook and Instagram.
Women hurt by birth control drugs and devices may be eligible to sue over their injuries.
Studies link hair relaxers to uterine/ovarian cancer. Lawsuits seek to hold companies accountable.
Family members may have been eligible to file Camp Lejeune water contamination lawsuits.
People are filing gastroparesis lawsuits after using drugs like Ozempic®, Wegovy® and Mounjaro™.
While litigation can take years to complete from start to finish, our firm is always working for our clients, no matter how long it takes or how hard it gets.
Motley Rice attorneys and support personnel are dedicated to representing clients and working with co-counsel located throughout the United States and around the world.
Comprehensive, up-to-date news on the issues surrounding the litigation areas of Motley Rice LLC.
News, Learn about the latest happenings from lawsuits and other events impacting plaintiffs.
Motley Rice lawyers share their insights on litigation and more to inform people exploring their legal options.
This case is no longer active
Enhancing Merger Process: Coventry Health Care
The Legal Team
*We are no longer accepting new claims in this litigation.
Class action litigation following the announcement of mergers and acquisitions can result in investor-friendly deal improvements that benefit shareholders. Motley Rice represented three public pension funds as court-appointed sole lead counsel challenging the $7.2 billion acquisition of Coventry Health Care, Inc., by Aetna, Inc.
Plaintiffs alleged that the defendants breached their fiduciary duties to Coventry’s shareholders by undertaking a flawed process, involving a conflicted financial advisor, to sell Coventry at a time when it was poised for remarkable growth as a result of recent government healthcare reforms.
After significant expedited discovery, a negotiated settlement was reached that provided for investor-friendly improvements to the deal’s terms, enhanced disclosures and the opportunity for a potential bidder to make a “last chance” offer for Coventry.
If you have questions regarding cases similar to the In re Coventry Health Care, Inc. Securities Litigation settlement or if you would like to discuss a potential case, contact our securities team by email or call 1.800.768.4026.
*Prior results do not guarantee a similar outcome.